Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b-Reference-Cited by-同舟云学术

Peginterferon alpha-2b plus ribavirin for treatment of chronic hepatitis C with severe fibrosis: a multicentre randomized controlled trial comparing two doses of peginterferon alpha-2b

Published:2006-12 Issue:12 Volume:13 Page:811-820
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Abergel A.,Hezode C.,Leroy V.,Barange K.,Bronowicki J. P.,Tran A.,Alric L.,Castera L.,Bernard P.-H.,Henquell C.,Lafeuille H.,Ughetto S.,Darcha C.,Chevallier M.,Martineau N.,Dubost S.,Randl K.,Dhumeaux D.,Bommelaer G.,Bonny C.,

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2893.2006.00768.x/fullpdf

Reference20 articles.

1. Morbidity and mortality in compensated cirrhosis type C: A retrospective follow-up study of 384 patients

2. Natural history of compensated viral cirrhosis: a prospective study on the incidence and hierarchy of major complications

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Meðferð lifrarbólgu C með peg-interferóni og ríbavíríni á Íslandi 2002-2012;Læknablaðið;2017-03-03

2. Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus;Gut and Liver;2016-07-15

3. Interleukin-28B gene non-TT allele strongly predicts treatment failure for genotype 1 infected chronic hepatitis C patients with advanced fibrosis: a case control study;BMC Infectious Diseases;2015-03-26

4. A meta-analysis platform methodology for determining the comparative effectiveness of antihepatitis C virus regimens;Journal of Comparative Effectiveness Research;2015-03

5. Re-re-treatment of hepatitis C virus: Eight patients who relapsed twice after direct-acting-antiviral drugs;World Journal of Gastroenterology;2015